Can drug delivery systems deliver value in the new pharmaceutical marketplace?
Economic evaluation of pharmaceuticals: what are reasonable standards for clinical evidence-the Australian experience
Drug treatment in acute porphyria
Homoeopathy: past, present and future
The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine
Population pharmacokinetics of clozapine evaluated with the nonparametric maximum likelihood method
Thiopurine drugs in the treatment of childhood leukaemia: the influence of inherited thiopurine methyltransferase activity on drug metabolism and cytotoxicity
Tolerance to the repolarization effects of rac-sotalol during long-term treatment
Effects of prostacyclin on renal haemodynamics, renal tubular function and vasoactive hormones in healthy humans. A placebo-controlled dose-response study
Integrated pharmacokinetics and pharmacodynamics of Ro 48-6791, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects
Integrated pharmacokinetics and pharmacodynamics of Ro 48-8684, a new benzodiazepine, in comparison with midazolam during first administration to healthy male subjects
Inhibition of CYP2C9 by selective serotonin reuptake inhibitors in vitro: studies of phenytoin p-hydroxylation
Diltiazem-cyclosporin pharmacokinetic interaction-dose-response relationship
Metabolic interactions of selected antimalarial and non-antimalarial drugs with the major pathway (3-hydroxylation) of quinine in human liver microsomes
Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system database
Fundamentals of Psychopharmacology, 2nd edition.
Principles of Neuropsychopharmacology